Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![scottstocksman Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1928107551456935936.png) Scotts Stocks [@scottstocksman](/creator/twitter/scottstocksman) on x XXX followers
Created: 2025-07-22 13:55:07 UTC

💊 Despite clinical setbacks, Novo Nordisk remains undervalued. Analysts see 30%+ upside from its ~$91 average target—making it a dip-buy worth considering.
#BuyTheDip #HealthcareStocks


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947656659310153912/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/scottstocksman/status/1947656659310153912)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

scottstocksman Avatar Scotts Stocks @scottstocksman on x XXX followers Created: 2025-07-22 13:55:07 UTC

💊 Despite clinical setbacks, Novo Nordisk remains undervalued. Analysts see 30%+ upside from its ~$91 average target—making it a dip-buy worth considering. #BuyTheDip #HealthcareStocks

XXX engagements

Engagements Line Chart

Related Topics stocks $nvo stocks healthcare

Post Link

post/tweet::1947656659310153912
/post/tweet::1947656659310153912